TFRC promotes the proliferation, migration, and invasion of osteosarcoma cells by increasing the intracellular iron content and RRM2 expression
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Transferrin receptor (TFRC) is highly expressed in osteosarcoma, correlating with poor survival. Inhibiting TFRC reduces cancer cell proliferation and invasion by decreasing iron uptake and RRM2 expression.
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Background
- Transferrin receptor (TFRC) is a known cancer biomarker due to its high expression in various tumors.
- The specific role of TFRC in osteosarcoma (OS) remains understudied.
- This research investigates TFRC's function in osteosarcoma cell proliferation, invasion, and migration.
Purpose Of The Study
- To analyze TFRC expression in osteosarcoma tissues and patient survival data.
- To elucidate the mechanism by which TFRC influences osteosarcoma cell behavior.
- To explore the relationship between TFRC, iron transport, and RRM2 in osteosarcoma.
Main Methods
- Expression analysis of TFRC in OS using public databases, qRT-PCR, Western blotting, and immunohistochemistry.
- Functional studies involving TFRC knockdown via shRNA in OS cell lines (143B, U2OS).
- In vivo tumor growth assessment in nude mice xenograft models and mechanistic studies involving iron levels and RRM2 expression.
Main Results
- TFRC expression is elevated in osteosarcoma and linked to poorer patient survival.
- TFRC knockdown significantly impaired OS cell proliferation, migration, and invasion.
- TFRC knockdown reduced intracellular iron and RRM2 protein levels, with observed inhibition of tumor growth in vivo.
Conclusions
- Osteosarcoma cells utilize TFRC to enhance proliferation, migration, and invasion.
- TFRC overexpression increases intracellular iron, subsequently boosting RRM2 expression and activity.
- Targeting TFRC presents a potential therapeutic strategy for osteosarcoma.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...